drugset / Trial / NCT00416468
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
RandomizedCrossoverOpen-labelTreatment
Summary
This study will assess the bioavailability of aliskiren and valsartan as a single tablet compared to the same doses of the two drugs given as two separate tablets in healthy subjects.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | 75 mg | — |
| Subject | Valsartan | Unknown | 160 mg | — |
Indications
No indication recorded.